CRYSTALLINE FORMS OF 5-CHLORO-N4-[2-(DIMETHYLPHOSPHORYL)PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE

Crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed herein. La présente invention concerne des formes cristallines de brigatinib, des compositions pharmaceutiques les comprenant et leurs procédés de prép...

Full description

Saved in:
Bibliographic Details
Main Authors SHARMA, PRADEEP, ROZAMUS, LEONARD W
Format Patent
LanguageEnglish
French
Published 16.11.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed herein. La présente invention concerne des formes cristallines de brigatinib, des compositions pharmaceutiques les comprenant et leurs procédés de préparation et d'utilisation.
Bibliography:Application Number: CA20152965169